Ovid Therapeutics Inc (OVID) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Ovid Therapeutics Inc. (OVID) barqarorligi dori vositalarini ishlab chiqishda ESG standartlari va bioetikaning joriy etilishi bilan tasdiqlanadi. Uzoq muddatli qarzlarning sof aktivlarga nisbati moliyaviy chidamlilikni vizuallashtiradi, bunda 0.05 ushbu ko'rsatkichning so'nggi qiymatini aks ettiradi. Operatsion asos bolalar epilepsiyasi terapiyasi uchun noyob ekotizim yaratishga tayanadi, sog'liqni saqlashning gumanitar maqomi esa kompaniyaning ilmiy jarayonini geosiyosiy xatarlardan himoya qiladi.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_OVID_-_Ovid-Therapeutics-Inc._-_Long-Term-Debt-to-Equity-Ratio "OVID - Ovid Rx Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 31.10.2026 oraligʻida | 👁️GURU.Markets👁️")
Ovid Therapeutics Inc. kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Ovid Therapeutics Inc.|OVID - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Ovid Rx|OVID - Kompaniyaning umumiy qarzi|Qarzning balans kapitallashuviga nisbati Ovid Therapeutics Inc.|OVID - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Ovid Therapeutics|Shoshilinch likvidlik koeffitsiyenti ovidrx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:ovidrx.com
Kamyob kasalliklar uchun dori vositalarini ishlab chiqish FDA tartibga soluvchi to'siqlarini yengib o'tish uchun ulkan R&D investitsiyalarini talab qiladi. Ovid Therapeutics Inc. (OVID) uchun joriy uzoq muddatli qarzlarning kapitalga nisbati tendentsiyasi kompaniyaning kapitaliga nisbatan uzoq muddatli majburiyatlar ulushini aks ettiradi. Ushbu ko'rsatkich moliyaviy leverajni va moliyalashtirish tuzilmasining barqarorligini baholash imkonini beradi. Ushbu nisbatning oshishi kengayish maqsadida kredit yukining ortayotganidan dalolat beradi, past qiymat esa kapital avtonomiyasini va defolt risklarining minimallashtirilganini tasdiqlaydi.
Muhim raqobatchilar
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli majburiyatlarning kapitalga nisbati harmonybiosciences.com HRMY|Uzoq muddatli qarzning o'z kapitaliga nisbati BHVN (Biohaven)|Uzoq muddatli qarzning o'z kapitaliga nisbati AMLX (Amylyx Pharmaceuticals Inc)|Uzoq muddatli qarzning kapitalga nisbati TRVI (Trevi Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Praxis Corp (PRAX)|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|CBLL (ceribell.com) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alector - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|OMER (Omeros Corp.) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati NGNE|ACIU (acimmune.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VYGR (Voyager Therapeutics, Inc.)|Neumora (NMRA) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TVGN (Tevogen Bio Inc.)|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com (CGTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Cassava Sciences Inc - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ASRT|COYA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Vistagen - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acumenpharm.com ABOS|CRVO: Uzoq muddatli qarzning o'z kapitaliga nisbati|Alterity Therapeutics - Uzoq muddatli kreditlarning kapitalga nisbati|CLNN: Uzoq muddatli qarzning kapitalga nisbati|PEPG - Uzoq muddatli qarzdorlikning kapitalga nisbati|JUNS (Jupiter Neurosciences Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati relmada.com (RLMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati Annovis Bio (ANVS)|Uzoq muddatli qarzdorlikning kapitalga nisbati gracetx.com|Firefly Neuroscience Inc - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KLTO|NeuroSense Therapeutics, Ltd. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati revivapharma.com RVPH|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi NRXS|HSDT (Helius Medical Technologies, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio Corp (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (Neuphoria Therapeutics Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati minervaneurosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Athira Pharma ATHA|Addex Therapeutics Ltd. (ADXN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ALZN: Uzoq muddatli qarzning o'z kapitaliga nisbati|CYCN: Uzoq muddatli qarzning o'z kapitaliga nisbati|PTIX: Uzoq muddatli qarzning kapitalga nisbati|KTTA - Uzoq muddatli qarzdorlikning kapitalga nisbati|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ATXI (Avenue Therapeutics Inc.)|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati CHRO (Chromocell Therapeutics)|Eliem Therapeutics, Inc. (ELYM) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ITCI: Uzoq muddatli qarzning o'z kapitaliga nisbati|LBPH - Uzoq muddatli qarzning kapitalga nisbati|Marinus (MRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|Uzoq muddatli majburiyatlarning kapitalga nisbati sagerx.com SAGE|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Anew Medical Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati